{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:10:57Z","timestamp":1776100257339,"version":"3.50.1"},"reference-count":109,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Information"],"abstract":"<jats:p>The evolvement of COVID-19 vaccines is rapidly being revolutionized using artificial intelligence-based technologies. Small compounds, peptides, and epitopes are collected to develop new therapeutics. These substances can also guide artificial intelligence-based modeling, screening, or creation. Machine learning techniques are used to leverage pre-existing data for COVID-19 drug detection and vaccine advancement, while artificial intelligence-based models are used for these purposes. Models based on artificial intelligence are used to evaluate and recognize the best candidate targets for future therapeutic development. Artificial intelligence-based strategies can be used to address issues with the safety and efficacy of COVID-19 vaccine candidates, as well as issues with manufacturing, storage, and logistics. Because antigenic peptides are effective at eliciting immune responses, artificial intelligence algorithms can assist in identifying the most promising COVID-19 vaccine candidates. Following COVID-19 vaccination, the first phase of the vaccine-induced immune response occurs when major histocompatibility complex (MHC) class II molecules (typically bind peptides of 12\u201325 amino acids) recognize antigenic peptides. Therefore, AI-based models are used to identify the best COVID-19 vaccine candidates and ensure the efficacy and safety of vaccine-induced immune responses. This study explores the use of artificial intelligence-based approaches to address logistics, manufacturing, storage, safety, and effectiveness issues associated with several COVID-19 vaccine candidates. Additionally, we will evaluate potential targets for next-generation treatments and examine the role that artificial intelligence-based models can play in identifying the most promising COVID-19 vaccine candidates, while also considering the effectiveness of antigenic peptides in triggering immune responses. The aim of this project is to gain insights into how artificial intelligence-based approaches could revolutionize the development of COVID-19 vaccines and how they can be leveraged to address challenges associated with vaccine development. In this work, we highlight potential barriers and solutions and focus on recent improvements in using artificial intelligence to produce COVID-19 drugs and vaccines, as well as the prospects for intelligent training in COVID-19 treatment discovery.<\/jats:p>","DOI":"10.3390\/info14120665","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T10:04:47Z","timestamp":1702893887000},"page":"665","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Revolutionizing Vaccine Development for COVID-19: A Review of AI-Based Approaches"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9204-0434","authenticated-orcid":false,"given":"Aritra","family":"Ghosh","sequence":"first","affiliation":[{"name":"Department of Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL 33431, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2354-4986","authenticated-orcid":false,"given":"Maria M.","family":"Larrondo-Petrie","sequence":"additional","affiliation":[{"name":"Department of Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL 33431, USA"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-329X","authenticated-orcid":false,"given":"Mirjana","family":"Pavlovic","sequence":"additional","affiliation":[{"name":"Department of Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL 33431, USA"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Albalawi, U., and Mustafa, M. (2022). Current Artificial intelligence (AI) Techniques, Challenges, and Approaches in Controlling and Fighting COVID-19: A review. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19105901"},{"key":"ref_2","unstructured":"(2023, December 13). Can Artificial Intelligence Help Us Design Vaccines?. Available online: https:\/\/www.brookings.edu\/articles\/can-artificial-intelligence-help-us-design-vaccines\/."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lv, H., Lv, H., Shi, L., Shi, L., Berkenpas, J.W., Berkenpas, J.W., Dao, F.-Y., Dao, F.-Y., Zulfiqar, H., and Zulfiqar, H. (2021). Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design. Briefings Bioinform., 22.","DOI":"10.1093\/bib\/bbab320"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"110894","DOI":"10.1016\/j.jtbi.2021.110894","article-title":"Network models to evaluate vaccine strategies towards herd immunity in COVID-19","volume":"531","author":"Tetteh","year":"2021","journal-title":"J. Theor. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Fiscon, G., Conte, F., Farina, L., and Paci, P. (2021). SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19. PLOS Comput. Biol., 17.","DOI":"10.1371\/journal.pcbi.1008686"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Arora, G., Joshi, J., Mandal, R.S., Shrivastava, N., Virmani, R., and Sethi, T. (2021). Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19. Pathogens, 10.","DOI":"10.3390\/pathogens10081048"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"103095","DOI":"10.1016\/j.ipm.2022.103095","article-title":"Investigating the COVID-19 vaccine discussions on Twitter through a multilayer network-based approach","volume":"59","author":"Bonifazi","year":"2022","journal-title":"Inf. Process. Manag."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1007\/s00521-022-08127-y","article-title":"A residual network-based framework for COVID-19 detection from CXR images","volume":"35","author":"Kibriya","year":"2022","journal-title":"Neural Comput. Appl."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chen, J., Hoops, S., Marathe, A., Mortveit, H., Lewis, B., Venkatramanan, S., Haddadan, A., Bhattacharya, P., Adiga, A., and Vullikanti, A. (2021). Prioritizing allocation of COVID-19 vaccines based on social contacts increases vaccination effectiveness. medRxiv.","DOI":"10.1101\/2021.02.04.21251012"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Tetteh, J.N.A., Nguy, V.K., and Hernandez-Vargas, E.A. (2020). COVID-19 Network Model to Evaluate Vaccine Strategies towards Herd Immunity. medRxiv.","DOI":"10.1101\/2020.12.22.20248693"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: Milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_13","unstructured":"(2023, December 13). MIT Sloan Management Review. AI and the COVID-19 Vaccine: Moderna\u2019s Dave Johnson | MIT Sloan Management Review. Available online: https:\/\/sloanreview.mit.edu\/audio\/ai-and-the-covid-19-vaccine-modernas-dave-johnson\/."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/biologics1030020","article-title":"Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena","volume":"1","author":"Chavda","year":"2021","journal-title":"Biologics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2020.01581","article-title":"COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning","volume":"11","author":"Ong","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Sharma, A., Virmani, T., Pathak, V., Sharma, A., Pathak, K., Kumar, G., and Pathak, D. (2022). Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine. BioMed Res. Int., 2022.","DOI":"10.1155\/2022\/7205241"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1017\/S0950268822001418","article-title":"A machine learning algorithm to analyse the effects of vaccination on COVID-19 mortality","volume":"150","author":"Magazzino","year":"2022","journal-title":"Epidemiol. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Li, Y.-D., Chi, W.-Y., Su, J.-H., Ferrall, L., Hung, C.-F., and Wu, T.-C. (2020). Coronavirus vaccine development: From SARS and MERS to COVID-19. J. Biomed. Sci., 27.","DOI":"10.1186\/s12929-020-00695-2"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/pcmedi\/pbab001","article-title":"Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs","volume":"4","author":"Hosseini","year":"2021","journal-title":"Precis. Clin. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Srivastava, S., Verma, S., Kamthania, M., Kaur, R., Badyal, R.K., Saxena, A.K., Shin, H.-J., Kolbe, M., and Pandey, K.C. (2020). Structural basis for designing multiepitope vaccines against COVID-19 infection: In Silico vaccine design and validation. JMIR Bioinform. Biotechnol., 1.","DOI":"10.2196\/preprints.19371"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Barghash, R.F., Fawzy, I.M., Chandrasekar, V., Singh, A.V., Katha, U., and Mandour, A.A. (2021). In Silico Modeling as a Perspective in Developing Potential Vaccine Candidates and Therapeutics for COVID-19. Coatings, 11.","DOI":"10.3390\/coatings11111273"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/s41598-023-28785-9","article-title":"AI-accelerated protein-ligand docking for SARS-CoV-2 is 100-fold faster with no significant change in detection","volume":"13","author":"Clyde","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7294","DOI":"10.1080\/07391102.2020.1805019","article-title":"Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19","volume":"39","author":"Lokhande","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Waqas, M., Haider, A., Rehman, A., Qasim, M., Umar, A., Sufyan, M., Akram, H.N., Mir, A., Razzaq, R., and Rasool, D. (2021). Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening. BioMed Res. Int., 2021.","DOI":"10.1155\/2021\/1596834"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"100578","DOI":"10.1016\/j.imu.2021.100578","article-title":"Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for SARS-CoV-2","volume":"24","author":"Khan","year":"2021","journal-title":"Inform. Med. Unlocked"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1007\/s10489-021-02193-w","article-title":"Using artificial intelligence techniques for COVID-19 genome analysis","volume":"51","author":"Nawaz","year":"2021","journal-title":"Appl. Intell."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12539-021-00465-0","article-title":"Enabling Artificial Intelligence for Genome Sequence Analysis of COVID-19 and Alike Viruses","volume":"14","author":"Ahmed","year":"2021","journal-title":"Interdiscip. Sci. Comput. Life Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jiph.2022.01.011","article-title":"COVID-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery","volume":"15","author":"Bagabir","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Yagin, F.H., Cicek, I.B., Alkhateeb, A., Yagin, B., Colak, C., Azzeh, M., and Akbulut, S. (2023). Explainable artificial intelligence model for identifying COVID-19 gene biomarkers. Comput. Biol. Med., 154.","DOI":"10.1016\/j.compbiomed.2023.106619"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s12553-021-00601-2","article-title":"The prospective of Artificial Intelligence in COVID-19 Pandemic","volume":"11","author":"Swayamsiddha","year":"2021","journal-title":"Health Technol."},{"key":"ref_31","first-page":"1165","article-title":"Intelligent Medicine and Beyond","volume":"68","author":"Liu","year":"2023","journal-title":"Kexue Tongbao"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Floresta, G., Zagni, C., Gentile, D., Patamia, V., and Rescifina, A. (2022). Artificial Intelligence Technologies for COVID-19 De Novo Drug Design. Int. J. Mol. Sci., 23.","DOI":"10.20944\/preprints202203.0032.v1"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"704256","DOI":"10.3389\/fmed.2021.704256","article-title":"Artificial Intelligence for COVID-19: A Systematic Review","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1039\/D0CS01065K","article-title":"A critical overview of computational approaches employed for COVID-19 drug discovery","volume":"50","author":"Muratov","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gurung, A.B., Ali, M.A., Lee, J., Farah, M.A., and Al-Anazi, K.M. (2021). An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19. BioMed Res. Int., 2021.","DOI":"10.1155\/2021\/8853056"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.dsx.2020.05.008","article-title":"A review of modern technologies for tackling COVID-19 pandemic","volume":"14","author":"Kumar","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-0716-1787-8_3","article-title":"Fighting COVID-19 with Artificial Intelligence","volume":"2390","author":"Monteleone","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"728469","DOI":"10.3389\/fddsv.2021.728469","article-title":"Post-Pandemic Drug Discovery and Development: Facing Present and Future Challenges","volume":"1","author":"Villoutreix","year":"2021","journal-title":"Front. Drug Discov."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zhavoronkov, A., Zagribelnyy, B., Zhebrak, A., Aladinskiy, V., Terentiev, V., Vanhaelen, Q., Bezrukov, D.S., Polykovskiy, D., Shayakhmetov, R., and Filimonov, A. (2020). Potential Non-Covalent SARS-CoV-2 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches and Reviewed by Human Medicinal Chemist in Virtual Reality. ChemRxiv.","DOI":"10.26434\/chemrxiv.12301457"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Tang, B., He, F., Liu, D., He, F., Wu, T., Fang, M., Niu, Z., Wu, Z., and Xu, D. (2022). AI-Aided Design of Novel Targeted Covalent Inhibitors against SARS-CoV-2. Biomolecules, 12.","DOI":"10.3390\/biom12060746"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Gao, K., Nguyen, D.D., Wang, R., and Wei, G.-W. (2020). Machine intelligence design of 2019-nCoV drugs. BioRxiv.","DOI":"10.1101\/2020.01.30.927889"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Hofmarcher, M., Mayr, A., Rumetshofer, E., Ruch, P., Renz, P., Schimunek, J., Seidl, P., Vall, A., Widrich, M., and Hochreiter, S. (2020). Large-Scale Ligand-Based Virtual Screening for SARS-CoV-2 Inhibitors Using Deep Neural Networks. arXiv.","DOI":"10.2139\/ssrn.3561442"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12539-020-00376-6","article-title":"Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov","volume":"12","author":"Zhang","year":"2020","journal-title":"Interdiscip. Sci. Comput. Life Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.csbj.2020.03.025","article-title":"Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model","volume":"18","author":"Beck","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41392-021-00568-6","article-title":"An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19","volume":"6","author":"Ge","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"FHu, F., Jiang, J., and Yin, P. (2022). Prediction of Potential Commercially Available Inhibitors against SARS-CoV-2 by Multi-Task Deep Learning Model. Biomolecules, 12.","DOI":"10.3390\/biom12081156"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1021\/acs.jproteome.0c00316","article-title":"Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning","volume":"19","author":"Zeng","year":"2020","journal-title":"J. Proteome Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e2025581118","DOI":"10.1073\/pnas.2025581118","article-title":"Network medicine framework for identifying drug-repurposing opportunities for COVID-19","volume":"118","author":"DGysi","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"113957","DOI":"10.1016\/j.jep.2021.113957","article-title":"Evaluating the Traditional Chinese Medicine (TCM) Officially Recommended in China for COVID-19 Using Ontology-Based Side-Effect Prediction Framework (OSPF) and Deep Learning","volume":"272","author":"Wang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"170433","DOI":"10.1109\/ACCESS.2020.3024238","article-title":"DeepH-DTA: Deep Learning for Predicting Drug-Target Interactions: A Case Study of COVID-19 Drug Repurposing","volume":"8","author":"Hawash","year":"2020","journal-title":"IEEE Access"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e9369","DOI":"10.7717\/peerj.9369","article-title":"Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection","volume":"8","author":"Demirci","year":"2020","journal-title":"PeerJ"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Kannan, S., Subbaram, K., Ali, S., and Kannan, H. (2020). The Role of Artificial Intelligence and Machine Learning Techniques: Race for COVID-19 Vaccine. Arch. Clin. Infect. Dis., 15.","DOI":"10.5812\/archcid.103232"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.38164\/AJPER\/11.1.2022.1-22","article-title":"A review on potential of artificial intelligence in diagnosis, drug discovery and vaccine development against COVID-19","volume":"11","author":"Yadav","year":"2022","journal-title":"Asian J. Pharm. Educ. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e20756","DOI":"10.2196\/20756","article-title":"Artificial Intelligence in the Fight Against COVID-19: Scoping Review","volume":"22","author":"Alajlani","year":"2020","journal-title":"J. Med Internet Res."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ahmed, F., Soomro, A.M., Salih AR, C., Samantasinghar, A., Asif, A., Kang, I.S., and Choi, K.H. (2022). A comprehensive review of artificial intelligence and network based approaches to drug repurposing in COVID-19. Biomed. Pharmacother., 153.","DOI":"10.1016\/j.biopha.2022.113350"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"100434","DOI":"10.1016\/j.imr.2020.100434","article-title":"Artificial intelligence and COVID-19: A multidisciplinary approach","volume":"9","author":"Ahuja","year":"2020","journal-title":"Integr. Med. Res."},{"key":"ref_58","first-page":"5898","article-title":"Artificial Intelligence and COVID-19: A Systematic Umbrella Review and Roads Ahead","volume":"34","author":"Adadi","year":"2022","journal-title":"J. King Saud Univ. Comput. Inf. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/frai.2020.00065","article-title":"Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development","volume":"3","author":"Arshadi","year":"2020","journal-title":"Front. Artif. Intell."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Bali, A., and Bali, N. (2022). Role of Artificial Intelligence in Fast-Track Drug Discovery and Vaccine Development for COVID-19, Elsevier. Elsevier eBooks.","DOI":"10.1016\/B978-0-323-90054-6.00006-4"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.dsx.2020.04.012","article-title":"Artificial Intelligence (AI) applications for COVID-19 pandemic","volume":"14","author":"Vaishya","year":"2020","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Kabra, R., and Singh, S. (2020). Evolutionary artificial intelligence based peptide discoveries for effective COVID-19 therapeutics. Biochim. et Biophys. Acta BBA-Mol. Basis Dis., 1867.","DOI":"10.1016\/j.bbadis.2020.165978"},{"key":"ref_63","unstructured":"(2023, December 13). An EPICC Study of SARS-CoV-2 Infection. Available online: https:\/\/www.hjf.org\/news\/epicc-study-sars-cov-2-infection."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Nu\u00f1ez, I.A., Huang, Y., and Ross, T.M. (2021). Next-Generation Computationally Designed Influenza Hemagglutinin Vaccines Protect against H5Nx Virus Infections. Pathogens, 10.","DOI":"10.3390\/pathogens10111352"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Coletti, S., and Bernardi, G. (2023). Exscalate4CoV, Springer. Available online: https:\/\/link.springer.com\/book\/10.1007\/978-3-031-30691-4.","DOI":"10.1007\/978-3-031-30691-4"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Baghban, R., Ghasemian, A., and Mahmoodi, S. (2023). Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19). Arch. Microbiol., 205.","DOI":"10.1007\/s00203-023-03480-5"},{"key":"ref_67","unstructured":"Tirumalaraju, D., and Tirumalaraju, D. (2023, December 13). Iktos and SRI to use AI for COVID-19 drug development. Available online: https:\/\/www.pharmaceutical-technology.com\/news\/iktos-sri-covid-19-drug-development\/."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Abdelmageed, M.I., Abdelmoneim, A.H., Mustafa, M.I., Elfadol, N.M., Murshed, N.S., Shantier, S.W., and Makhawi, A.M. (2020). Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach. BioMed Res. Int., 2020.","DOI":"10.1101\/2020.02.04.934232"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Sarkar, B., Ullah, M.A., Johora, F.T., Taniya, M.A., and Araf, Y. (2020). The Essential Facts of Wuhan Novel Coronavirus Outbreak in China and Epitope-based Vaccine Designing against COVID-19. bioRxiv.","DOI":"10.1101\/2020.02.05.935072"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Fast, E., Altman, R.B., and Chen, B. (2020). Potential T-cell and B-cell Epitopes of 2019-nCoV. bioRxiv.","DOI":"10.1101\/2020.02.19.955484"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"96","DOI":"10.28991\/SciMedJ-2020-02-SI-9","article-title":"Using in-silica Analysis and Reverse Vaccinology Approach for COVID-19 Vaccine Development","volume":"2","author":"Agarwal","year":"2020","journal-title":"SciMedicine J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e9572","DOI":"10.7717\/peerj.9572","article-title":"Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: An in silico approach","volume":"8","author":"Rahman","year":"2020","journal-title":"PeerJ"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1080\/07391102.2021.1977702","article-title":"In silico approach to design a multi-epitopic vaccine candidate targeting the non-mutational immunogenic regions in envelope protein and surface glycoprotein of SARS-CoV-2","volume":"40","author":"Priyadarshni","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Russo, G., Di Salvatore, V., Sgroi, G., Palumbo, G.A.P., A Reche, P., and Pappalardo, F. (2021). A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets. Briefings Bioinform., 23.","DOI":"10.1093\/bib\/bbab403"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cels.2020.06.009","article-title":"Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Syst."},{"key":"ref_76","unstructured":"Baruah, A. (2023, December 13). TCS Partners with CSIR to Find Cure for COVID-19 | Mint. Available online: https:\/\/www.livemint.com\/companies\/news\/tcs-partners-with-csir-to-find-cure-for-covid-19-11585561862046.html."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Krishnamurthy, A., and Goel, P. (2022). Artificial Intelligence-Based Drug Screening and Drug Repositioning Tools and Their Application in the Present Scenario, Elsevier. Elsevier eBooks.","DOI":"10.1016\/B978-0-323-91172-6.00010-8"},{"key":"ref_78","unstructured":"(2023, December 13). Exscientia\u2014Exscientia Announces Joint Initiative to Identify COVID-19 Drugs with Diamond Light Source and Scripps Research. Available online: https:\/\/investors.exscientia.ai\/press-releases\/press-release-details\/2020\/Exscientia-announces-joint-initiative-to-identify-COVID-19-drugs-with-Diamond-Light-Source-and-Scripps-Research\/default.aspx."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aiopen.2020.07.001","article-title":"AI-driven drug discovery: A boon against COVID-19?","volume":"1","author":"Kaushik","year":"2020","journal-title":"AI Open"},{"key":"ref_80","first-page":"1","article-title":"Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines","volume":"2022","author":"Jomah","year":"2022","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Richardson, P.J., Robinson, B.W., Smith, D.P., and Stebbing, J. (2022). The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19. Vaccines, 10.","DOI":"10.3390\/vaccines10060951"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"\u00d6zsezer, G., and Mermer, G. (2022). Using Artificial Intelligence in the COVID-19 Pandemic: A Systematic Review. Acta MEDICA Iran.","DOI":"10.18502\/acta.v60i7.10208"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbiomolbio.2023.02.003","article-title":"A systematic review of artificial intelligence-based COVID-19 modeling on multimodal genetic information","volume":"179","author":"Sekaran","year":"2023","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_84","unstructured":"Velu, A. (2023, December 13). Impact of COVID Vaccination on the Globe Using Data Analytics. Velu | International Journal of Sustainable Development in Computing Science. Available online: https:\/\/ijsdcs.com\/index.php\/ijsdcs\/article\/view\/11."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Meghla, T.I., Rahman, M.M., Biswas, A.A., Hossain, J.T., and Khatun, T. (2021, January 6\u20138). Supply Chain Management with Demand Forecasting of COVID-19 Vaccine using Blockchain and Machine Learning. Proceedings of the 2021 12th International Conference on Computing Communication and Networking Technologies (ICCCNT), Kharagpur, India.","DOI":"10.1109\/ICCCNT51525.2021.9580006"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e12073","DOI":"10.7717\/peerj.12073","article-title":"Potential of artificial intelligence to accelerate diagnosis and drug discovery for COVID-19","volume":"9","author":"Mikkili","year":"2021","journal-title":"PeerJ"},{"key":"ref_87","first-page":"100047","article-title":"Exploring the Challenges of the COVID-19 Vaccine Supply Chain Using Social Media Analytics: A Global Perspective","volume":"2","author":"Mardani","year":"2023","journal-title":"Sustain. Technol. Entrep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"101378","DOI":"10.1016\/j.seps.2022.101378","article-title":"A new vaccine supply chain network under COVID-19 conditions considering system dynamic: Artificial intelligence algorithms","volume":"85","author":"Kamran","year":"2023","journal-title":"Socio-Econ. Plan. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"130820","DOI":"10.1109\/ACCESS.2020.3009328","article-title":"Artificial Intelligence (AI) and Big Data for Coronavirus (COVID-19) Pandemic: A Survey on the State-of-the-Arts","volume":"8","author":"Pham","year":"2020","journal-title":"IEEE Access"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Almars, A.M., Gad, I., and Atlam, E.-S. (2022). Applications of AI and IoT in COVID-19 Vaccine and Its Impact on Social Life. Stud. Comput. Intell., 115\u2013127.","DOI":"10.1007\/978-3-030-91103-4_7"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Mellado, B., Wu, J., Kong, J.D., Bragazzi, N.L., Asgary, A., Kawonga, M., Choma, N., Hayasi, K., Lieberman, B., and Mathaha, T. (2021). Leveraging Artificial Intelligence and Big Data to Optimize COVID-19 Clinical Public Health and Vaccination Roll-Out Strategies in Africa. Int. J. Environ. Res. Public Health, 18.","DOI":"10.2139\/ssrn.3787748"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2217\/fvl-2020-0130","article-title":"The role of artificial intelligence in tackling COVID-19","volume":"15","author":"Arora","year":"2020","journal-title":"Futur. Virol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/oalib.1106628","article-title":"Applications of Artificial Intelligence in Combating COVID-19: A Systematic Review","volume":"7","author":"Enughwure","year":"2020","journal-title":"OALib"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.drudis.2020.06.020","article-title":"Emerging vaccine delivery systems for COVID-19","volume":"25","author":"Theobald","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1007\/s40747-021-00424-8","article-title":"A Systematic Review on AI\/ML Approaches against COVID-19 Outbreak","volume":"7","author":"Dogan","year":"2021","journal-title":"Complex Intell. Syst."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Zaidi, S.A.J., Tariq, S., and Belhaouari, S.B. (2021). Future Prediction of COVID-19 Vaccine Trends Using a Voting Classifier. Data, 6.","DOI":"10.3390\/data6110112"},{"key":"ref_97","unstructured":"Gerke, S., Minssen, T., and Cohen, G. (2020). Artificial Intelligence in Healthcare, Academic Press."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Chavali, M. (2020). Artificial Intelligence and Machine Learning Approach towards COVID-19. Nanomed. Nanotechnol. Open Access, 5.","DOI":"10.23880\/NNOA-16000201"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Aljedaani, W., Saad, E., Rustam, F., D\u00edez, I.d.l.T., and Ashraf, I. (2022). Role of Artificial Intelligence for Analysis of COVID-19 Vaccination-Related Tweets: Opportunities, Challenges, and Future Trends. Mathematics, 10.","DOI":"10.3390\/math10173199"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1258159","DOI":"10.3389\/fbrio.2023.1258159","article-title":"Artificial intelligence in accelerating vaccine development\u2014Current and future perspectives","volume":"2","author":"Kaushik","year":"2023","journal-title":"Front. Bacteriol."},{"key":"ref_101","unstructured":"Bello, C. (2023, December 13). How Leveraging the Power of AI Is Changing the Way Moderna Vaccines Are Made and Distributed. Available online: https:\/\/www.euronews.com\/next\/2023\/06\/22\/how-leveraging-the-power-of-ai-is-changing-the-way-moderna-vaccines-are-made-and-distribut."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10796-021-10131-x","article-title":"The Role of Artificial Intelligence in Fighting the COVID-19 Pandemic","volume":"23","author":"Piccialli","year":"2021","journal-title":"Inf. Syst. Front."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1517\/14712598.8.11.1659","article-title":"Personalized vaccines: The emerging field of vaccinomics","volume":"8","author":"Poland","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"90316","DOI":"10.1109\/ACCESS.2019.2926642","article-title":"Leveraging Machine Learning and Big Data for Smart Buildings: A Comprehensive Survey","volume":"7","author":"Qolomany","year":"2019","journal-title":"IEEE Access"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cts.12884","article-title":"Precision Medicine, AI, and the Future of Personalized Health Care","volume":"14","author":"Johnson","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e005292","DOI":"10.1136\/jitc-2022-005292","article-title":"Artificial intelligence and radiomics: Fundamentals, applications, and challenges in immunotherapy","volume":"10","author":"Dercle","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13643-022-01941-4","article-title":"Strategies to overcome vaccine hesitancy: A systematic review","volume":"11","author":"Singh","year":"2022","journal-title":"Syst. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4161\/hv.34360","article-title":"Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety","volume":"11","author":"Alicino","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.7861\/fhj.2021-0095","article-title":"Artificial intelligence in healthcare: Transforming the practice of medicine","volume":"8","author":"Bajwa","year":"2021","journal-title":"Future Healthc. J."}],"container-title":["Information"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2078-2489\/14\/12\/665\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:40:47Z","timestamp":1760132447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2078-2489\/14\/12\/665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":109,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["info14120665"],"URL":"https:\/\/doi.org\/10.3390\/info14120665","relation":{},"ISSN":["2078-2489"],"issn-type":[{"value":"2078-2489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]}}}